NEW YORK (360Dx) – Co-Diagnostics, fresh off its IPO last week that raised $7.1 million in gross proceeds, is eyeing the developing markets for its technologies, and it expects to begin manufacturing and launching infectious disease diagnostics tests soon from a manufacturing facility in India, the company's CEO Dwight Egan said in an interview.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

A trial upgrade to 360Dx Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try 360Dx Premium now.

Already a 360Dx Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.